Emerald Advisers’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $688K | Sell |
41,035
-6,062
| -13% | -$102K | 0.03% | 161 |
|
|
2025
Q1 | $724K | Sell |
47,097
-2,653
| -5% | -$40.8K | 0.03% | 145 |
|
|
2024
Q4 | $1.1M | Sell |
49,750
-35,809
| -42% | -$789K | 0.04% | 133 |
|
|
2024
Q3 | $1.54M | Sell |
85,559
-1,188
| -1% | -$21.4K | 0.06% | 125 |
|
|
2024
Q2 | $1.41M | Sell |
86,747
-16,739
| -16% | -$272K | 0.06% | 129 |
|
|
2024
Q1 | $1.46M | Buy |
103,486
+37,272
| +56% | +$526K | 0.06% | 129 |
|
|
2023
Q4 | $691K | Sell |
66,214
-1,238
| -2% | -$12.9K | 0.03% | 166 |
|
|
2023
Q3 | $688K | Buy |
+67,452
| New | +$688K | 0.03% | 159 |
|